Organisation paid for research Program year 2021 Source: CMS Open Payments

Amici Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$553,252

53 payments

Through program year 2021, Amici Clinical Research, LLC is reported as receiving $553,252 in research payments, across 53 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$4,733	1
2020	Research	$12,893	6
2019	Research	$535,626	46

Breakdown

Who paid Research payments · program years 2019–2021

AbbVie, Inc. $527,386 44 payments
Merck Sharp & Dohme Corporation $25,866 9 payments

Studies the money was for Research payments · program years 2019–2021

M16-100 $527,386 44 payments
A Phase 3b Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Gefapixant in Adult Participants with Recent Onset Chronic Cough $13,292 3 payments
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability, Efficacy, and Immunogenicity of V590 rVSV G-SARS-CoV-2-S, Live in Healthy Individuals 16 Years of Age or Older $10,500 1 payment
A Phase 3b Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Gefapixant in Adult Participants with Recent Onset Chronic Cough $1,574 4 payments
A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals with Pre-cirrhotic Nonalcoholic Steatohepatitis $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.